Sumitomo Mitsui Trust Group, Inc.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1475365
CHIYODA-KU, TOKYO, M0
Position in NBIX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$36,318,347
+$7,276,396 QoQ
Shares Held
215,488
-2.3% QoQ
Ownership
0.212%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#78
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sumitomo Mitsui Trust Group, Inc. holds $237,661,566 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (15.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,340,457 | $79,294,683 | |
| 2 | ZTS |
Zoetis Inc.
|
1,020,052 | $73,300,936 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
85,496 | $46,324,297 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
215,488 | $36,318,347 | |
| 5 | VTRS |
Viatris Inc
|
99,887 | $1,586,205 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
11,310 | $464,049 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
7,715 | $267,479 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
10,557 | $105,570 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,318,347 | 215,488 | Shares | Defined | 2026-07-30 | |
| 2026-03-31 | $29,041,951 | 220,449 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $28,744,118 | 202,666 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $31,064,690 | 221,290 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $29,598,486 | 235,488 | Shares | Defined | 2025-07-31 | |
| 2025-03-31 | $25,599,254 | 231,458 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $31,784,980 | 232,857 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $26,724,242 | 231,941 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $33,514,797 | 243,443 | Shares | Defined | 2024-07-19 | |
| 2024-03-31 | $34,833,764 | 252,565 | Shares | Defined | 2024-04-19 | |
| 2023-12-31 | $32,140,875 | 243,935 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $26,049,712 | 231,553 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $22,868,127 | 242,504 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $28,840,310 | 284,927 | Shares | Defined | 2023-04-27 | |
| 2022-12-31 | $33,926,932 | 284,050 | Shares | Defined | 2023-01-30 | |
| 2022-09-30 | $30,187,962 | 284,229 | Shares | Defined | 2022-10-21 | |
| 2022-06-30 | $27,590,739 | 283,040 | Shares | Defined | 2022-07-26 | |
| 2022-03-31 | $26,242,312 | 279,918 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $25,128,897 | 295,044 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $25,364,262 | 264,459 | Shares | Defined | 2021-10-25 | |
| 2021-06-30 | $26,294,501 | 270,186 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $29,689,063 | 305,286 | Shares | Defined | 2021-04-30 | |
| 2020-12-31 | $29,377,449 | 306,494 | Shares | Defined | 2021-02-05 | |
| 2020-09-30 | $32,571,411 | 338,721 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $51,953,090 | 425,845 | Shares | Defined | 2020-07-27 | |
| 2020-03-31 | $47,919,619 | 553,664 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||